Background
Radiofrequency ablation for ventricular arrhythmias is limited by inability to visualize tissue destruction, by reversible conduction block resulting from edema surrounding lesions, and by insufficient lesion depth. We hypothesized that transcatheter needle injection of caustic agents doped with gadolinium contrast under real-time magnetic resonance imaging (MRI) could achieve deep, targeted and irreversible myocardial ablation which would be immediately visible.
Methods and Results
Under real-time MRI guidance, ethanol or acetic acid was injected into the myocardium of 8 swine using MRI-conspicuous needle catheters. Chemoablation lesions had identical geometry by in vivo and ex vivo MRI as well as histopathology, both immediately and after 12(7–17) days. Whereas ethanol caused stellate lesions with patchy areas of normal myocardium, acetic acid caused homogeneous circumscribed lesions of irreversible necrosis. Ischemic cardiomyopathy was created in 10 additional swine by sub-selective transcoronary ethanol administration into non-contiguous territories. After 12(8–15) days, real-time MRI guided chemoablation — with 2–5 injections to create a linear lesion —successfully eliminated the isthmus and local abnormal voltage activities.
Conclusions
Real-time MRI guided chemoablation with acetic acid enabled the intended arrhythmic substrate, whether deep or superficial, to be visualized immediately and ablated irreversibly. In an animal model of ischemic cardiomyopathy, obliteration of a conductive isthmus both anatomically and functionally, and abolition of local abnormal voltage activities in areas of heterogeneous scar was feasible. This represents the first report of MRI guided myocardial chemoablation, an approach that could improve efficacy of arrhythmic substrate ablation in the thick ventricular myocardium.